Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells

Oncology Reports - Tập 27 Số 4 - Trang 1027-1034 - 2012
Kexiu Zhu1, Lihong Chen2, Xiaobing Han3, Jia Wang3, Jue Wang4
1Department of Obstetrics and Gynecology, First Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
2Department of Obstetrics and Gynecology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068;
3Department of Obstetrics and Gynecology, First Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061;
4Xi'an Jiaotong University, Xi'an, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Greven, 1999, Current developments in the treatment of newly diagnosed cervical cancer, Hematol Oncol Clin North Am, 13, 275, 10.1016/S0889-8588(05)70165-9

Cornelio, 2009, Emerging therapeutic agents for cervical cancer, Recent Pat Anticancer Drug Discov, 4, 196, 10.2174/157489209789206887

Sardi, 2005, Neoadjuvant chemotherapy in cervical cancer: a new trend, Curr Opin Obstet Gynecol, 17, 43, 10.1097/00001703-200502000-00008

Moore, 2003, Neoadjuvant chemotherapy for cervical cancer, Expert Opin Pharmacother, 4, 859, 10.1517/14656566.4.6.859

Tao, 2008, Chemotherapy for recurrent and metastatic cervical cancer, Gynecol Oncol, 110, S67, 10.1016/j.ygyno.2008.04.024

Brabec, 2002, Molecular aspects of resistance to antitumor platinum drugs, Drug Resist Updat, 5, 147, 10.1016/S1368-7646(02)00047-X

Djeu, 2009, Clusterin and chemoresistance, Adv Cancer Res, 105, 77, 10.1016/S0065-230X(09)05005-2

Konishi, 1998, Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma, Gynecol Oncol, 70, 365, 10.1006/gyno.1998.5077

Britten, 2000, ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells, Int J Cancer, 89, 453, 10.1002/1097-0215(20000920)89:5<453::AID-IJC9>3.0.CO;2-E

Takara, 2006, An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy, Curr Pharm Des, 12, 273, 10.2174/138161206775201965

Lage, 2006, MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance, Curr Drug Targets, 7, 813, 10.2174/138945006777709566

Xia, 2008, Specific reversal of MDR1/P-gp-dependent multidrug resistance by RNA interference in colon cancer cells, Oncol Rep, 20, 1433

Peinado, 2007, Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nat Rev Cancer, 7, 415, 10.1038/nrc2131

Yang, 2004, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis, Cell, 117, 927, 10.1016/j.cell.2004.06.006

Iseri, 2011, Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern, Biomed Pharmacother, 65, 40, 10.1016/j.biopha.2010.10.004

Yang, 2006, Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines, Clin Cancer Res, 12, 4147, 10.1158/1078-0432.CCR-06-0038

Wang, 2004, Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells, Oncogene, 23, 474, 10.1038/sj.onc.1207128

Li, 2009, Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells, Clin Cancer Res, 15, 2657, 10.1158/1078-0432.CCR-08-2372

Cheng, 2007, Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel, Cancer Res, 67, 1979, 10.1158/0008-5472.CAN-06-1479

Shibata, 2008, Twist expression in patients with cervical cancer is associated with poor disease outcome, Ann Oncol, 19, 81, 10.1093/annonc/mdm344

Kwok, 2005, Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target, Cancer Res, 65, 5153, 10.1158/0008-5472.CAN-04-3785

Martin, 2005, Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer, Ann Surg Oncol, 12, 488, 10.1245/ASO.2005.04.010

Yan-Qi, 2007, Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer, Pathology, 39, 470, 10.1080/00313020701570053

Puisieux, 2006, A twist for survival and cancer progression, Br J Cancer, 94, 13, 10.1038/sj.bjc.6602876

Chen, 2010, Overcoming drug resistance by regulating nuclear receptors, Adv Drug Deliv Rev, 62, 1257, 10.1016/j.addr.2010.07.008

Comerford, 2002, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene, Cancer Res, 62, 3387

Sampath, 2001, Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1, J Biol Chem, 276, 39359, 10.1074/jbc.M103429200

El-Osta, 2002, Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation, Mol Cell Biol, 22, 1844, 10.1128/MCB.22.6.1844-1857.2002

Gomez-Martinez, 2007, Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines, Mol Cancer Res, 5, 641, 10.1158/1541-7786.MCR-06-0177

Chen, 2007, Human pregnane X receptor and resistance to chemotherapy in prostate cancer, Cancer Res, 67, 10361, 10.1158/0008-5472.CAN-06-4758

Yang, 2008, Direct regulation of TWIST by HIF-1alpha promotes metastasis, Nat Cell Biol, 10, 295, 10.1038/ncb1691

Ding, 2010, Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells, J Cancer Res Clin Oncol, 136, 1697, 10.1007/s00432-010-0828-5